• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.2010 年全国健康访谈调查中的结直肠癌检测使用情况,包括 CT 结肠成像。
Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.
2
Utilization Pattern of Computed Tomographic Colonography in the United States: Analysis of the U.S. National Health Interview Survey.美国计算机断层结肠成像的使用模式:美国国家健康访谈调查分析
Cancer Prev Res (Phila). 2021 Jan;14(1):113-122. doi: 10.1158/1940-6207.CAPR-20-0175. Epub 2020 Sep 16.
3
Trends in colorectal cancer test use among vulnerable populations in the United States.美国脆弱人群中结直肠癌检测使用的趋势。
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.
4
Colorectal cancer test use from the 2005 National Health Interview Survey.2005年美国国家健康访谈调查中的结直肠癌检测使用情况。
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.
5
Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.ACRIN 全国 CT 结肠成像试验数据与三个癌症干预和监测建模网络微观模拟的比较经济评估。
Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3.
6
Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.国家健康访谈调查中的结直肠癌筛查趋势:不同方式对总体筛查率影响的分析。
Cancer Prev Res (Phila). 2024 Jun 4;17(6):275-280. doi: 10.1158/1940-6207.CAPR-23-0443.
7
Insurance Coverage for CT Colonography Screening: Impact on Overall Colorectal Cancer Screening Rates.CT结肠成像筛查的保险覆盖范围:对总体结直肠癌筛查率的影响。
Radiology. 2017 Sep;284(3):717-724. doi: 10.1148/radiol.2017170924. Epub 2017 Jul 11.
8
9
Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.在符合筛查条件的美国成年人中,使用粪便潜血试验/粪便免疫化学试验进行结直肠癌筛查,医生办公室与家庭的接受率比较。
Cancer Med. 2019 Dec;8(17):7408-7418. doi: 10.1002/cam4.2604. Epub 2019 Oct 21.
10
Participation in colorectal cancer screening: a review.参与结直肠癌筛查:一项综述。
J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22. doi: 10.1093/jnci/89.19.1406.

引用本文的文献

1
Use of Cancer Screening Tests, United States, 2023.2023年美国癌症筛查测试的使用情况
Prev Chronic Dis. 2025 Aug 14;22:E52. doi: 10.5888/pcd22.250139.
2
Utilization of colorectal cancer screening tests: a systematic review and time trend analysis of nationally representative data.结直肠癌筛查测试的应用:基于全国代表性数据的系统评价和时间趋势分析
EClinicalMedicine. 2024 Aug 21;75:102783. doi: 10.1016/j.eclinm.2024.102783. eCollection 2024 Sep.
3
Using the consolidated framework for implementation research to identify church leaders' perspectives on contextual determinants of community-based colorectal cancer screening for Black Kentuckians.运用实施研究的综合框架来确定教会领袖对肯塔基州黑人社区结直肠癌筛查背景决定因素的看法。
Implement Sci Commun. 2024 Jul 25;5(1):83. doi: 10.1186/s43058-024-00621-9.
4
Factors associated with prior completion of colorectal cancer and hepatitis C virus screenings among community health center patients: a cross-sectional study to inform a multi-behavioral educational intervention.社区卫生中心患者中与先前完成结直肠癌和丙型肝炎病毒筛查相关的因素:一项横断面研究,为多行为教育干预提供信息
J Behav Med. 2024 Apr;47(2):295-307. doi: 10.1007/s10865-023-00460-4. Epub 2023 Dec 21.
5
Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.2021 年美国最新的乳腺癌、宫颈癌和结直肠癌筛查检测应用情况。
Prev Chronic Dis. 2023 Oct 26;20:E94. doi: 10.5888/pcd20.230071.
6
Reducing disparities and achieving health equity in colorectal cancer screening.缩小结直肠癌筛查中的差距并实现健康公平。
Tech Innov Gastrointest Endosc. 2023;25(3):284-296. doi: 10.1016/j.tige.2023.02.007. Epub 2023 Mar 1.
7
Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.美国社会人口因素与乳腺癌、宫颈癌和结直肠癌筛查之间的关联。
Cancer Causes Control. 2023 Dec;34(12):1073-1084. doi: 10.1007/s10552-023-01758-z. Epub 2023 Jul 24.
8
Disparities in Compliance with Colorectal Cancer Screening: Evidence from Two US National Surveys.结直肠癌筛查的依从性差异:来自两项美国全国性调查的证据。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1173-1180. doi: 10.31557/APJCP.2023.24.4.1173.
9
Colorectal cancer screening barriers and facilitators among Jordanians: A cross-sectional study.约旦人结直肠癌筛查的障碍与促进因素:一项横断面研究。
Prev Med Rep. 2023 Feb 13;32:102149. doi: 10.1016/j.pmedr.2023.102149. eCollection 2023 Apr.
10
Colorectal Cancer Screening Prevalence, Perceived Barriers, and Preference for Screening Colonoscopy Among Hospitalized Women.住院女性的结直肠癌筛查普及率、认知障碍及对筛查结肠镜检查的偏好。
Turk J Gastroenterol. 2022 Nov;33(11):901-908. doi: 10.5152/tjg.2022.21567.

本文引用的文献

1
Cancer screening - United States, 2010.癌症筛查 - 美国,2010 年。
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):41-5.
2
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.基于人群的结直肠癌筛查中结肠镜与非肠道准备 CT 结肠成像的参与率和检出率:一项随机对照试验。
Lancet Oncol. 2012 Jan;13(1):55-64. doi: 10.1016/S1470-2045(11)70283-2. Epub 2011 Nov 15.
3
Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010.生命体征:2002-2010 年美国结直肠癌筛查、发病和死亡情况。
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):884-9.
4
Trends in colorectal cancer test use among vulnerable populations in the United States.美国脆弱人群中结直肠癌检测使用的趋势。
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.
5
Validity of self-reported colorectal cancer test use in different racial/ethnic groups.不同种族/族裔群体中自我报告的结直肠癌检测使用的有效性。
Fam Pract. 2011 Dec;28(6):683-8. doi: 10.1093/fampra/cmr026. Epub 2011 May 12.
6
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey.美国癌症筛查的数据和趋势:来自 2005 年全国健康访谈调查的结果。
Cancer. 2010 Oct 15;116(20):4872-81. doi: 10.1002/cncr.25215.
7
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.美国初级保健医生对粪便潜血检测的看法及做法:严重偏离循证医学建议
J Gen Intern Med. 2010 Aug;25(8):833-9. doi: 10.1007/s11606-010-1328-7. Epub 2010 Apr 10.
8
Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system.改善退伍军人事务医疗系统中的结直肠癌筛查与护理。
Clin Colorectal Cancer. 2009 Jan;8(1):22-8. doi: 10.3816/CCC.2009.n.004.
9
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.评估结直肠癌筛查的检测策略:美国预防服务工作组的决策分析
Ann Intern Med. 2008 Nov 4;149(9):659-69. doi: 10.7326/0003-4819-149-9-200811040-00244. Epub 2008 Oct 6.
10
Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.结直肠癌筛查:美国预防服务工作组建议声明
Ann Intern Med. 2008 Nov 4;149(9):627-37. doi: 10.7326/0003-4819-149-9-200811040-00243. Epub 2008 Oct 6.

2010 年全国健康访谈调查中的结直肠癌检测使用情况,包括 CT 结肠成像。

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

机构信息

Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

DOI:10.1158/1055-9965.EPI-12-0192
PMID:22490320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4489134/
Abstract

BACKGROUND

Recommended colorectal cancer (CRC) screening tests for adults ages 50 to 75 years include home fecal occult blood tests (FOBT), sigmoidoscopy with FOBT, and colonoscopy. A newer test, computed tomographic (CT) colonography, has been recommended by some, but not all, national organizations.

METHODS

We analyzed 2010 National Health Interview Survey data, including new CT colonography questions, from respondents ages 50 to 75 years (N = 8,952). We (i) assessed prevalence of CRC test use overall, by test type, and by sociodemographic and health care access factors and (ii) assessed reported reasons for not having a CRC test.

RESULTS

The age-standardized percentage of respondents reporting FOBT, sigmoidoscopy, or colonoscopy within recommended time intervals was 58.3% [95% confidence interval (CI), 57.0-59.6]. Colonoscopy was the most commonly reported test [within past 10 years: 54.6% (95% CI, 53.2-55.9)]. Home FOBT and sigmoidoscopy with FOBT were less frequently used [FOBT within past year: 8.8% (95% CI, 8.1-9.6); sigmoidoscopy within past 5 years with FOBT within past 3 years: 1.3% (95% CI, 1.0-1.6)]. CT colonography was rare: 1.3% (95% CI, 1.0-1.7). Increasing age, education, income, having health care insurance, and having a usual source of health care were associated with higher CRC test use. Test use within recommended time intervals was particularly low among individuals ages 50 to 64 years without health care insurance [21.2% (95% CI, 18.3-24.4)]. The most common reason for nonuse was "no reason or never thought about it."

CONCLUSIONS

About 40% of Americans ages 50 to 75 years do not meet the recommendations for having CRC screening tests.

IMPACT

Expanded health care coverage and greater awareness of CRC screening are needed to further decrease CRC mortality.

摘要

背景

推荐给 50 至 75 岁成年人的结直肠癌(CRC)筛查测试包括家庭粪便潜血测试(FOBT)、乙状结肠镜检查加 FOBT 和结肠镜检查。一些但不是所有的国家组织都推荐了一种新的测试,即计算机断层扫描(CT)结肠成像。

方法

我们分析了 2010 年全国健康访谈调查数据,包括来自 50 至 75 岁受访者的新 CT 结肠成像问题(N=8952)。我们(i)按测试类型和社会人口统计学及医疗保健获取因素评估总体 CRC 测试使用率,以及(ii)评估未进行 CRC 测试的报告原因。

结果

报告在推荐时间间隔内进行 FOBT、乙状结肠镜检查或结肠镜检查的受访者年龄标准化百分比为 58.3%[95%置信区间(CI),57.0-59.6]。结肠镜检查是最常报告的测试[过去 10 年:54.6%(95%CI,53.2-55.9)]。家庭 FOBT 和乙状结肠镜检查加 FOBT 的使用率较低[过去一年 FOBT:8.8%(95%CI,8.1-9.6);过去 5 年内乙状结肠镜检查加过去 3 年内 FOBT:1.3%(95%CI,1.0-1.6)]。CT 结肠成像则很少见:1.3%(95%CI,1.0-1.7)。年龄较大、受教育程度较高、收入较高、有医疗保险和有常规医疗来源与更高的 CRC 测试使用率相关。在没有医疗保险的 50 至 64 岁人群中,按建议时间间隔进行的测试使用率特别低[21.2%(95%CI,18.3-24.4)]。未使用的最常见原因是“没有理由或从未考虑过”。

结论

约 40%的 50 至 75 岁美国人不符合 CRC 筛查测试的建议。

影响

需要扩大医疗保健覆盖范围和提高对 CRC 筛查的认识,以进一步降低 CRC 死亡率。